CAM2029 not checked

Camurus AB

FollowEvery change as it happens, and a Monday email
Stage
in the EU
Next date
Phase 3 trial completes
Trials
2 active
4 in total · 3 in the EU
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“CAM2029 (octreotide subcutaneous depot) 20 mg will be administered every 2 weeks as a subcutaneous injection”In the company’s words, NCT05050942 on ClinicalTrials.gov
Tested for
Gastro-enteropancreatic Neuroendocrine Tumor, Polycystic Liver Disease
Main trialPhase 3
“The purpose of this study is to compare the effectiveness and safety of CAM2029 to octreotide LAR or lanreotide ATG in patients with advanced, well-differentiated GEP-NET. Patients who experience progressive disease in the randomized part of the study may proceed to an open-label extension part with intensified treatment with CAM2029.”In the company’s words, NCT05050942 on ClinicalTrials.gov
Other names
octreotide subcutaneous depot

Other drugs for Gastro-enteropancreatic Neuroendocrine Tumor

All 8 drugs for Gastro-enteropancreatic Neuroendocrine Tumor

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials4

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting Nov 2026 A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET
Phase 2/3Active, not recruiting 5 Feb 2025 A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD
Phase 3Completed 2 May 2023 A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly
Phase 3Completed 24 Apr 2025 A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow CAM2029

Following is part of Solo: you see every change to CAM2029 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in